143 related articles for article (PubMed ID: 12400156)
1. [Atherosclerosis and sensitive determination of oxidized LDL using monoclonal antibody].
Itabe H
Yakugaku Zasshi; 2002 Oct; 122(10):745-53. PubMed ID: 12400156
[TBL] [Abstract][Full Text] [Related]
2. Oxidized low-density lipoproteins: what is understood and what remains to be clarified.
Itabe H
Biol Pharm Bull; 2003 Jan; 26(1):1-9. PubMed ID: 12520163
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of oxidized phosphatidylcholines formed in oxidized low density lipoprotein by lecithin-cholesterol acyltransferase.
Itabe H; Hosoya R; Karasawa K; Jimi S; Saku K; Takebayashi S; Imanaka T; Takano T
J Biochem; 1999 Jul; 126(1):153-61. PubMed ID: 10393333
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal accumulation of oxidized phosphatidylcholine-apolipoprotein B complex in macrophages: intracellular fate of oxidized low density lipoprotein.
Itabe H; Suzuki K; Tsukamoto Y; Komatsu R; Ueda M; Mori M; Higashi Y; Takano T
Biochim Biophys Acta; 2000 Sep; 1487(2-3):233-45. PubMed ID: 11018475
[TBL] [Abstract][Full Text] [Related]
5. Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein.
Itabe H; Yamamoto H; Suzuki M; Kawai Y; Nakagawa Y; Suzuki A; Imanaka T; Takano T
J Biol Chem; 1996 Dec; 271(52):33208-17. PubMed ID: 8969177
[TBL] [Abstract][Full Text] [Related]
6. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody.
Itabe H; Yamamoto H; Imanaka T; Shimamura K; Uchiyama H; Kimura J; Sanaka T; Hata Y; Takano T
J Lipid Res; 1996 Jan; 37(1):45-53. PubMed ID: 8820101
[TBL] [Abstract][Full Text] [Related]
7. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease.
Faviou E; Vourli G; Nounopoulos C; Zachari A; Dionyssiou-Asteriou A
Free Radic Res; 2005 Apr; 39(4):419-29. PubMed ID: 16028367
[TBL] [Abstract][Full Text] [Related]
8. Oxidative modification of LDL: its pathological role in atherosclerosis.
Itabe H
Clin Rev Allergy Immunol; 2009 Aug; 37(1):4-11. PubMed ID: 18987785
[TBL] [Abstract][Full Text] [Related]
9. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects.
Shoji T; Nishizawa Y; Fukumoto M; Shimamura K; Kimura J; Kanda H; Emoto M; Kawagishi T; Morii H
Atherosclerosis; 2000 Jan; 148(1):171-7. PubMed ID: 10580183
[TBL] [Abstract][Full Text] [Related]
10. Detection of oxidized low-density lipoproteins in gingival crevicular fluid from dental patients.
Sakiyama Y; Kato R; Inoue S; Suzuki K; Itabe H; Yamamoto M
J Periodontal Res; 2010 Apr; 45(2):216-22. PubMed ID: 19778326
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides.
Itabe H; Takeshima E; Iwasaki H; Kimura J; Yoshida Y; Imanaka T; Takano T
J Biol Chem; 1994 May; 269(21):15274-9. PubMed ID: 8195164
[TBL] [Abstract][Full Text] [Related]
12. Oxidized LDL in carotid plaques and plasma associates with plaque instability.
Nishi K; Itabe H; Uno M; Kitazato KT; Horiguchi H; Shinno K; Nagahiro S
Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1649-54. PubMed ID: 12377744
[TBL] [Abstract][Full Text] [Related]
13. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease.
Toshima S; Hasegawa A; Kurabayashi M; Itabe H; Takano T; Sugano J; Shimamura K; Kimura J; Michishita I; Suzuki T; Nagai R
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2243-7. PubMed ID: 11031210
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
Radulescu L; Stancu C; Antohe F
Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.
Imanaga Y; Sakata N; Takebayashi S; Matsunaga A; Sasaki J; Arakawa K; Nagai R; Horiuchi S; Itabe H; Takano T
Atherosclerosis; 2000 Jun; 150(2):343-55. PubMed ID: 10856526
[TBL] [Abstract][Full Text] [Related]
16. Circulating oxidized LDL, increased in patients with acute myocardial infarction, is accompanied by heavily modified HDL.
Sawada N; Obama T; Koba S; Takaki T; Iwamoto S; Aiuchi T; Kato R; Kikuchi M; Hamazaki Y; Itabe H
J Lipid Res; 2020 Jun; 61(6):816-829. PubMed ID: 32291330
[TBL] [Abstract][Full Text] [Related]
17. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease.
Andican G; Seven A; Uncu M; Cantaşdemir M; Numan F; Burçak G
Scand J Clin Lab Invest; 2008; 68(6):473-8. PubMed ID: 18609113
[TBL] [Abstract][Full Text] [Related]
18. The Significance of Oxidized Low-Density Lipoprotein in Body Fluids as a Marker Related to Diseased Conditions.
Itabe H; Kato R; Sawada N; Obama T; Yamamoto M
Curr Med Chem; 2019; 26(9):1576-1593. PubMed ID: 29521196
[TBL] [Abstract][Full Text] [Related]
19. Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice.
Kato R; Mori C; Kitazato K; Arata S; Obama T; Mori M; Takahashi K; Aiuchi T; Takano T; Itabe H
Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):33-9. PubMed ID: 18988894
[TBL] [Abstract][Full Text] [Related]
20. Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.
Trpkovic A; Resanovic I; Stanimirovic J; Radak D; Mousa SA; Cenic-Milosevic D; Jevremovic D; Isenovic ER
Crit Rev Clin Lab Sci; 2015; 52(2):70-85. PubMed ID: 25537066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
